In this series the early mortality is 4.9% (25 patients). A total of 406 patients (81%) ,have been followed up for 3.811.3 years, late mortality is 5.9% (24 patients). Thromboembolic inci dents (7.8%), prosthetic valve endocarditis (PVE) (4.9%), hemorrhage (2.9%), paravalvular leakage (0.7%) and hemolysis (0.2%) were the encountered complications. In 24 patients redo valve surgery was performed because of thrombotic prosthesis dysfunction, PVE, para valvular leakage, and extensive hemolysis.
Comparison of early and late mortality and postoperative functional capacities has not shown any superiorities of one type of mechanical prosthesis over another.